Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1032 to 1081 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1032\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ran binding protein 11. [source:refseq;acc:nm\_016338]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6138.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6717.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09418\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1033\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6080.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6653.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09417\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1034\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase alpha and beta forms (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-i/iii). [source:swissprot;acc:q00266]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6152.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6732.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09414\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1035\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i, delta isoform (ec 2.7.1.-) (cki-delta) (ckid). [source:swissprot;acc:p48730]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5054.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5530.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09407\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1036\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase (ec 3.1.3.11) (d-fructose-1,6-bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:p09467]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6077.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6649.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09404\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1037\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
monoglyceride lipase; lysophospholipase-like. [source:refseq;acc:nm\_007283]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6544.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7159.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1038\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myb proto-oncogene protein (c-myb). [source:swissprot;acc:p10242]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5417.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5924.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09348\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1039\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myb-related protein b (b-myb). [source:swissprot;acc:p10244]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5418.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5923.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09304\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1040\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding region containing protein 2 (hepatocellular carcinoma protein 1) (splicing factor hcc1). [source:swissprot;acc:q14498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5421.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5926.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1041\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myb-related protein a (a-myb). [source:swissprot;acc:p10243]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5419.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5922.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09294\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1042\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to lim domain only 7 (fragment). [source:sptrembl;acc:q8n6m2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6434.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09287\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1043\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
15 kda selenoprotein precursor. [source:swissprot;acc:o60613]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6344.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6933.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09283\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1044\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mbd2 (methyl-cpg-binding protein)-interacting zinc finger protein. [source:refseq;acc:nm\_015517]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4757.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5198.91\vspace{3pt}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09279\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1045\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
immature colon carcinoma transcript 1 (digestion substraction 1) (ds- 1). [source:swissprot;acc:q14197]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5364.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5862.09\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1046\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle tropomodulin (sk-tmod) (tropomodulin 4). [source:swissprot;acc:q9nzq9]\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4757.46\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5198.91\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1047\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitous tropomodulin (u-tmod) (tropomodulin 3). [source:swissprot;acc:q9nyl9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1048\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tropomodulin 1 (erythrocyte tropomodulin) (e-tmod). [source:swissprot;acc:p28289]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1049\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 9 (sh3 and px domain-containing protein 1) (sdp1 protein). [source:swissprot;acc:q9y5x1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1050\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal tropomodulin (n-tmod) (tropomodulin 2). [source:swissprot;acc:q9nzr1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1051\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein dlx-2. [source:swissprot;acc:q07687]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1052\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein dlx-5. [source:swissprot;acc:p56178]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1053\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fetal brain protein 239 (239fb). [source:swissprot;acc:q15777]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1054\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein dlx-3. [source:swissprot;acc:o60479]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1055\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
activated p21cdc42hs kinase. [source:refseq;acc:nm\_005781]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1056\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 interacting protein 2 isoform 1; tak1-binding protein 2. [source:refseq;acc:nm\_015093]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1057\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tata element modulatory factor (tmf). [source:swissprot;acc:p82094]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5412.23\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5913.4\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0926\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1058\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
scy1-like 1; telomerase regulation-associated protein; ht019 protein; telomerase regulation-associated protein; n-terminal kinase-like protein; teratoma-associated tyrosine kinase; n-terminal kinase-like. [source:refseq;acc:nm\_020680]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1059\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin-specific chaperone c (tubulin-folding cofactor c) (cfc). [source:swissprot;acc:q15814]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5719.01\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6248.6\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1060\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative acyl-coa thioester hydrolase cgi-16 (ec 3.1.2.-). [source:swissprot;acc:q9y305]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1061\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear pore complex protein nup98 (nucleoporin nup98) (98 kda nucleoporin). [source:swissprot;acc:p52948]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5412.23\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5913.4\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1062\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ammecr1 protein. [source:refseq;acc:nm\_015365]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1063\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mrna-associated protein mrnp 41 (rae1 protein homolog). [source:swissprot;acc:p78406]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1064\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead-box protein. [source:refseq;acc:nm\_018665]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5719.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6248.6\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1065\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-(apurinic or apyrimidinic site) lyase (ec 4.2.99.18) (ap endonuclease 1) (apex nuclease) (apen) (ref-1 protein). [source:swissprot;acc:p27695]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6393.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6984.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09245\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1066\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucyl-trna synthetase. [source:refseq;acc:nm\_020117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5417.06\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5917.79\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09244\vspace{3pt}}\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1067\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable leucyl-trna synthetase, mitochondrial precursor (ec 6.1.1.4) (leucine--trna ligase) (leurs). [source:swissprot;acc:q15031]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5417.07\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1.09243\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1068\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec15a. [source:swissprot;acc:q8tag9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6201.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6774.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09237\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1069\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor 2 (ef-2). [source:swissprot;acc:p13639]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5494.73\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6001.08\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09215\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1070\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
metabotropic glutamate receptor 2 precursor (mglur2). [source:swissprot;acc:q14416]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1071\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
metabotropic glutamate receptor 3 precursor (mglur3). [source:swissprot;acc:q14832]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1072\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 3 (von hippel-lindau binding protein 1) (vhl binding protein-1) (vbp-1) (hibbj46). [source:swissprot;acc:q15765]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5207.39\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5687.2\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09214\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1073\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prefoldin subunit 2 (hspc231). [source:swissprot;acc:q9uhv9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1074\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uxt protein (ubiquitously expressed transcript protein) (hspc024). [source:swissprot;acc:q9ubk9]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1075\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 1 (ec 2.7.7.41) (cdp-diglyceride synthetase 1) (cdp-diglyceride pyrophosphorylase 1) (cdp- diacylglycerol synthase 1) (cds 1) (ctp:phosphatidate cytidylyltransferase 1) (cdp-dag synthase 1) (cdp-dg synthetase 1). [source:swissprot;acc:q92903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6441.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7034.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09211\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1076\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 4 (na+/sulfate cotransporter sut-1). [source:swissprot;acc:q9ukg4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.19\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09202\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1077\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 3 (sodium-dependent high-affinity dicarboxylate transporter 2) (na(+)/dicarboxylate cotransporter 3) (nadc-3) (hnadc3). [source:swissprot;acc:q8wwt9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.22\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1078\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 1 (renal sodium/sulfate cotransporter) (na(+)/sulfate cotransporter) (hnasi-1). [source:swissprot;acc:q9bzw2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.19\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1079\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 2 (renal sodium/dicarboxylate cotransporter) (na(+)/dicarboxylate cotransporter 1) (nadc-1). [source:swissprot;acc:q13183]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.22\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1080\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 2. [source:swissprot;acc:o15127]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6439.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7031.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.092\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1081\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 3. [source:swissprot;acc:o14828]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/